IP Verse

Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab

Patent No. EP2676967 (titled "Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab") was filed by Biogen Idec MA on Feb 28, 2007. The application was issued on Aug 14, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
POLPHARMA BIOLOGICSMay 14, 2020WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2676967

BIOGEN IDEC MA
Application Number
EP13175987A
Filing Date
Feb 28, 2007
Status
Revoked
Feb 17, 2023
Publication Date
Aug 14, 2019
External Links
Slate, Register , Google Patents